Dec 7 (Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.



Latest News

ABC: Rwandan police say 5 Congolese refugees killed in protests

ABC: Trump's stance on gun regulation has evolved after series of mass shootings

Reuters: Ice hockey: Russians top Czechs to reach final

Daily Mail: Alan Bennett to debut new play about NHS hospital

Daily Mail: Australian gambling crackdown pushes William Hill to...

Daily Mail: Malcolm Turnbull drinking when told Barnaby Joyce had quit

Daily Mail: EU to propose pan-EU covered bond rules

Daily Mail: Mixed martial arts-McGregor plotting UFC return

Daily Mail: Latvian financial supervisor sees no 'panic' over ABLV...

Daily Mail: UK regulator to cap prices BT can charge rivals for use...

Daily Mail: India offers Saudi Arabia stake in second phase of...

CBS: Ivanka Trump gets a red-carpet welcome to South Korea

ABC: Ivanka Trump arrives in South Korea ahead of Olympics closing ceremony

USA Today: Koshechkin shuts out Czechs to put Russians in Olympic final

USA Today: The Latest: Swiss curlers beat Canada for bronze medal

Daily Mail: Britons brave chill as Beast from the East approaches

Daily Mail: Former S.African soldier sentenced to death in S.Sudan

Daily Mail: Ex-footballer Andy ColeĀ talks about his kidney transplant

Daily Mail: Britons could have to opt out of donating their organs

Daily Mail: Lauren Goodger flaunts toned figure in barely-there bikini

BBC: Naked man on tracks causes Edinburgh rail disruption

BBC: Irish Premiership: Ronnie McFall will demand total Glens commitment in Reds game

BBC: Former PoW, 96, attacked at home